ALS Network Celebrates Final Congressional Passage of ACT for ALS Reauthorization Act
Why now
Thesis: Rare-disease funding continuity matters for ALS-focused developers
Catalyst to watch: Presidential signature before September 30 expiration
Main risk: Appropriations could still lag authorization
Why it matters
Reauthorization of a rare-disease access law keeps a funding pathway alive for ALS therapies, but no specific company or dollar amount is cited.
Details
Bipartisan legislation now heads to the President's desk ahead of the September 30 expiration LOS ANGELES, Sept. 28, 2026 /PRNewswire/ -- Today, ALS Network celebrates the final congressional passage of the Accelerating Access to Critical Therapies (ACT) for ALS Reauthorization Act of...
Related assets & topics
HealthcareSources
- prnewswire · 2026-09-29 03:24 UTC